Company ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Equities
1541
CNE100006624
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.88 HKD | +0.16% | -0.77% | -56.92% |
Business Summary
Number of employees: 145
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cell Strain and Other Products
95.1
%
| 1 | 92.8 % | 0 | 95.1 % | -30.11% |
Testing Services
4.9
%
| 0 | 7.2 % | 0 | 4.9 % | -53.71% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -31.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wen Zhi Tian
CEO | Chief Executive Officer | - | 15-05-31 |
Qi Ying Lu
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 15-11-30 |
Zikai Xiong
PRN | Corporate Officer/Principal | - | 22-02-28 |
Ru liang Zhang
PRN | Corporate Officer/Principal | - | 17-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Tat Yeung
BRD | Director/Board Member | 55 | 22-05-31 |
Zhi Hua Yu
BRD | Director/Board Member | 57 | - |
Wen Zhi Tian
CEO | Chief Executive Officer | - | 15-05-31 |
Zhenping Zhu
BRD | Director/Board Member | - | - |
Xiao Yong Yu
BRD | Director/Board Member | 51 | - |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 15-11-30 |
Cong Xu
BRD | Director/Board Member | - | - |
Kendall Smith
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 374,157,695 | 69,612,628 ( 18.61 %) | 0 | 18.61 % |
Company contact information
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
Building 15, Lane 1000 Zhangheng Road
200120, Zhangjiang Science City
+86 21 3801 6387
http://cn.immuneonco.comSector
Sales per Business
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.92% | 616M | |
+20.03% | 126B | |
+23.61% | 117B | |
+23.26% | 27.52B | |
-18.07% | 20.87B | |
-15.13% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- 1541 Stock
- Company ImmuneOnco Biopharmaceuticals (Shanghai) Inc.